Table 1.

Patients' characteristics and treatment data

Variables		Cases	Rates (%)	Variables		Cases	Rates (%)
Age	≤50	141	53	Gender	Male	199	75
	>50	125	47		Female	67	25
T stage	T1	61	23	N stage	N0	31	12
	T2	110	41		N1	40	15
	T3	95	36		N2-3	195	73
Clinical stage	I	6	2	RT dose	Standard dose	234	88
	II	45	17		De-escalated dose	32	12
	III	188	71	IC	Yes	163	61
	IV	27	10		No	103	39
CC	Yes	181	68	AC	Yes	162	61
	No	85	32		No	104	39